BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Drug Development

  Repros Therapeutics Inc. Suspends Dosing of Proellex(R) and Provides Update on Financial Status

  August 3, 2009

   · 

  5 min read
• Drug Development

  FDA Lifts Partial Clinical Hold on Epilepsy Drug Says Icagen

  August 3, 2009

   · 

  1 min read
• Business

  Cardiac Science Inc. Reports Q2 Revenue of $36.1 Million

  August 3, 2009

   · 

  3 min read
• Drug Development

  Boehringer Ingelheim Corporation (JOBS) to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations

  August 3, 2009

   · 

  8 min read
• FDA

  AccuVein Vein Illuminator Receives European CE Mark

  August 3, 2009

   · 

  1 min read
• Deals

  Thoratec Corporation (JOBS) Drops Effort to Buy HeartWare

  August 3, 2009

   · 

  1 min read
• FDA

  FDA Approves Roche (JOBS), Genentech, Inc.'s (JOBS) Avastin for the Most Common Type of Kidney Cancer

  August 3, 2009

   · 

  8 min read
• Deals

  Talecris Biotherapeutics (JOBS) Still Planning IPO

  August 3, 2009

   · 

  1 min read
• Business

  Lilly BioVentures Spins Out from Eli Lilly and Company (JOBS)

  August 3, 2009

   · 

  1 min read
• Drug Development

  OSI Pharmaceuticals, Inc. Says Tarceva Extends Lung Cancer Survival

  August 3, 2009

   · 

  1 min read